Revising the definition of extensively drug-resistant tuberculosis. Go to Publication You Might Also Like Clofazimine: an old drug for never-ending diseases September 3, 2020 The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis January 9, 2020 Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection August 30, 2019 Possible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai. May 6, 2016 Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease August 30, 2019
The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis January 9, 2020
Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection August 30, 2019
Possible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai. May 6, 2016